more silence this week from mgmt.. Why won't th
Post# of 15624
Why won't they do more damage control to rebuild PPS? What's their incentive to tank PPS this low? I can't believe there's no interest in any of their products in the pipeline. Cannabis med is the next growth sector.
I could think of a few events to stop the bleeding..
1. PR that they will abandon RS and seek alternative method for funding (move to 5 cents)
2. PR about their MM cocktail formation that can kill 90% cancer cells and patent on the way... yes, mention Orphan Drug destination
3. tablet trail launch
We don't have to break the law like JF to get investor interested in the potential of this company.